Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
Br J Haematol. 2009 Jun;145(6):816-24. Epub 2009 Mar 26.PMID: 19344418 [PubMed - indexed for MEDLINE]Related articles